INHIBITORY EFFECTS OF ANCHUSA AZUREA EXTRACTS ON XANTHINE OXIDASE ACTIVITY AND ITS HYPOURICEMIC EFFECTS ON MICE by N, Boussoualim et al.
 
Original Article 
INHIBITORY EFFECTS OF ANCHUSA AZUREA EXTRACTS ON XANTHINE OXIDASE ACTIVITY 
AND ITS HYPOURICEMIC EFFECTS ON MICE 
 
1BOUSSOUALIM N, BAGHIANI A, KRACHE I, TRABSA H, KENOUF S, ARRAR L. 
1Laboratory of Applied Biochemistry, Faculty of Nature and Life Sciences, University Ferhat Abbas Setif 1, Setif 19000, Algeria 
Email: naouel_24@yahoo.fr   
Received: 13 May 2015 Revised and Accepted: 20 Jun 2015 
ABSTRACT 
Objective: The aim of the present study was to determine the effects of the polyphenols and flavonoids from Anchusa azurea on XO activities in vitro 
and on serum and liver uric acid levels in normal and potassium oxonate-induced hyper uricemic mice. In addition, the renal function of the mice 
after flavonoid administration was estimated by the determination of blood urea and creatinine analysis. 
Methods: In the present study, Anchusa azurea were extracted with solvent of varying polarity allowed its separation into four subfractions: crude 
extract (Cr) chloroform extract (ChE), ethyl acetate extract (AcE), and aqueous extracts (AqE). Total polyphenol and flavonoids contents of Anchusa 
azurea extracts were determined. The inhibitory activity of the extracts on the XO was evaluated and the type of inhibition was determined. 
Hyperuricemia is induced by intraperitoneally injection of potassium oxonate, the uric acid, urea and creatinine were measured in serum and 
supernatant of the liver. The effect of the extracts on renal function was evaluated. The rate of urea and creatinine levels can be indicators for the 
assessment of renal function. 
Results: AcE were the richest in polyphenols and ChE was the richest fraction in flavonoids. The inhibitory activity of the extracts on the XO was 
evaluated, the results obtained showed that the inhibition is dose-dependent and ChE and AcE have the best inhibitory effect (IC50= 0.334±0.006 
and 0.263±0.002 mg/ml, respectively), and both showed a noncompetitive type of inhibition. For antihyperuricemic effect, AqE and CrE caused a 
decrease in serum uric acid (a decrease of 66%) followed by ChE with a percentage of 29.22 %. The AcE keeps almost the same value of uric acid of 
"PO" group. For the supernatant, only CrE caused a significant decrease of liver uric acid (18.5±4.83 mg/l). This decrease can be explained by the 
significant inhibition of the XO by inhibition of the synthesis pathways of uric acid. Comparing the urea level of "OP" group (0.48 g/l), only extracts 
CrE-AA, AqE-AA (0.41g/l, 0.39 g/l) decreased the level of urea significantly (P ≤ 0.05) to the normal values of urea (0.34 g/l), we can conclude that 
the rate of urea and creatinine after treatment with plant extracts are normal and that the results of this study indicate the absence of renal damage 
in mice 
Conclusion: Anchusa azurea fractions have a strong inhibitory effect on xanthine oxidase and also have a significant lowering effect on serum and 
liver creatinine and urea levels in hyper uricemic mice. 
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INTRODUCTION  
Hyperuricemia is the most cited pathology involving XO. It is a 
pathological state that arises from overproduction (by XO) or under 
excretion (renal tubule disorders) of uric acid. As a result of 
hyperuricemia, insoluble uric acid forms microscopic crystals in the 
capillary vessels of joints. These crystals cause inflammation and 
sharp pain, which is termed acute gouty arthritis or acute gout [1]. 
Xanthine oxidase (XO) catalyses the oxidation of hypoxanthine and 
xanthine to uric acid. Therefore, XO inhibitors have been proposed 
as potential therapeutic agents for treating hyperuricemia as they 
could be used to block the biosynthesis of uric acid [2, 3]. Allopurinol 
is the most commonly used xanthine oxidase inhibitor prescribed 
clinically for the treatment of gout [4, 5]. However, the use of these 
agents is limited because of its undesirable effects [6, 7]. The search 
for better agents anti hyperuricemic is highly requested, this study 
represents an effort to find a new molecule hypouricemic. 
The use of natural products isolated from medicinal plants 
represents a good source of novel and clinically important drugs in 
connection with the treatment of some kinds of clinical disorders as 
hyperuricemia and gout. Flavonoids are widely found in plants and 
are known to possess biological and pharmacological activities, 
including anti-oxidative, anti-bacterial, anti-viral and anti-cancer 
activities. Flavonoids are also known to be potent inhibitors of 
several enzymes, including xanthine oxidase, cyclooxygenase and 
lipooxigenase [8]. 
As part of our effort to find antihyperuricemic agents from herbs: 
Anchusa azurea is used which belongs to the Borraginacea 
commonly known as ‘Hamham’, It is widely distributed in the 
Mediterranean region. Anchusa azurea is one of the medicinal plants 
largely used in Algeria. It shows various healthcare properties, 
especially antitussives, diuretic, anti inflammatory and as a 
cataplasm. Moreover, Anchusa azurea is used as a pomade for 
external use to treat wounds and burnings. The aim of the present 
study was to determine the effects of phenolic fractions from 
Anchusa azurea on XO activities and on serum and liver uric acid 
levels in normal and potassium oxonate-induced hyper uricemic 
mice. In addition, the renal function of the mice after the 
administration of plant extracts was estimated by the determination 
of blood urea and creatinine levels. 
MATERIALS AND METHODS 
Materials 
Anchusa azurea L. was collected from Borj Bouaririj A, Algeria in 
May 2010 and identified by Pr. Laouer H. (Department of vegetal 
biology, Setif 1 University). All other reagents were purchased from 
Sigma Chemicals (Germany), Fluka and Prolab. 
Extraction procedure  
The extractions were carried out using various polar and non-polar 
solvents. According to the method Markham (1982), the powdered 
plant material (100 g) was extracted with methanol, at room 
temperature for overnight. The MeOH extracts were combined and 
concentrated under reduced pressure on a rotary evaporator. MeOH 
extract (CrE) successively extracted with hexane, chloroform and 
ethyl acetate. Each fraction was evaporated to dryness under 
reduced pressure to give hexane (HE), chloroform (ChE), ethyl 
acetate (AcE), and the remaining aqueous (AqE) extracts.  
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Determination of total flavonoid contents 
The total flavonoid content of each extract was determined by a 
calorimetric method as described by Bahrain et al. (1996). Each 
sample (1 ml) was mixed with 1 ml of aluminum chloride (AlCl3) 
solution (2%) and allowed to stand for 15 min. The absorbance of 
the mixture was then determined at 430 nm versus prepared 
methanol blank. Results were expressed as equivalent quercetin and 
rutin (mg quercetin or rutin/g dried extract). 
Determination of total polyphenols 
Total phenolic content was determined by the Folin-Ciocalteu 
method [11]. 200 µl of diluted sample were added to 1 ml of 1:10 
diluted Folin–Ciocalteu reagent. After 4 min, 800 ml of saturated 
sodium carbonate solution (75 g/l) was added. After incubation for 
1h at room temperature, the absorbance at 765 nm was measured in 
triplicate. Gallic acid (0-160 μg/ml) was used for calibration of the 
standard curve. The results were expressed as microgram gallic acid 
equivalent (mg GAE)/mg of extract. 
Effect of extracts on XO 
Bacterial xanthine oxidase was purchased from Sigma, the effect of 
extracts on xanthine oxidation was examined spectro 
photometrically at 295 nm following the production of uric acid 
using an absorption coefficient of 9600 M-1 cm-1. Different 
concentrations of testing compounds were added to the samples 
before the enzyme had been added and their effect on the generation 
of uric acid was used to calculate regression lines and IC50 values. 
The reaction was started by the addition of XO. The enzyme activity 
of the control sample was set to 100% activity [12]. The type of 
inhibition of different extracts was determined by the Lineweaver-
Burk plot using varying concentrations of xanthine. 
Hypouricemic effects of extracts on potassium oxonate-induced 
hyperuricemia in mice  
Experiments were performed on adult male mice from the Pasteur 
Institute of Algeria weighing 25-30 g. Animal experiments in mice 
were conducted after the experiment procedures were revised and 
approved by the ethics committee of the university Ferhat Abbas 
SETIF1, Algeria. They were kept under standardized conditions 
(temperature 21-24 °C and a light/dark cycle of 12 hours/12 hours) 
and fed a normal laboratory diet. After 1 week of acclimatization, 
mice’s was divided into groups of 9-10 animals. Induction of 
hyperuricemia is made by injection intraperitoneally of 200 mg/kg 
of potassium oxonate, which is an uricase inhibitor [13]. After 1 hour 
the extracts were administered intraperitoneally (100 mg/kg). The 
mice are divided into 7 groups:  
• Group 1 (Control): untreated or injected with the vehicle (normal 
saline) normal group. 
• Group 2 (PO): injected with potassium oxonate. 
• Group 3 (PO+allopurinol): the group injected with potassium 
oxonate then treated with 10 mg/kg of allopurinol. 
• Group 4 (PO+CrE): injected with potassium oxonate then treated 
with 100 mg/kg of CrE. 
• Group 5 (PO+ChE): injected with potassium oxonate then treated 
with 100 mg/kg on of ChE. 
• Group 6 (PO+AcE): injected with potassium oxonate then treated 
with 100 mg/kg of AcE. 
• Group 7 (PO+AqE): injected with potassium oxonate then treated 
with 100 mg/kg of AqE. 
Whole blood samples were collected from mice on anesthetized mice 
and centrifuged at 1500 g for 5 minutes. The serum obtained was 
stored at-20 °C until use. Livers from each group were collected, 
rinsed with saline and homogenized in a phosphate buffer (50 mM, 
pH 7.8) and centrifuged at 8000 g for 15 min at 4 °C. The 
supernatant is used for the determination of uric acid [14, 15]. The 
concentration of uric acid in the serum and supernatant of the liver 
is determined by an enzymatic method.  
Statistical analysis  
All experiments were done in triplicate and results was reported as 
mean±SD. Data was analyzed by one way ANOVA. Statistically 
significant effects were further analyzed and means were compared 
using a Tukey test. Statistical significance was determined at p ≤0.05.  
RESULTS AND DISCUSSION 
Total phenolic and flavonoid content 
In order to characterize the different extracts, a total dosage of 
flavonoids and polyphenols is performed. The assay method of total 
polyphenols is the Folin-Ciocalteau [11]. Gallic acid was used as 
standard and total polyphenol content is expressed as micrograms 
of Gallic acid equivalents per milligram of extract (EAG µg/mg 
extract). The dosage of flavonoids is formed according to the method 
of aluminum trichloride [10] using as a standard the quercetin. The 
flavonoid content is expressed as micrograms of quercetin 
equivalents per milligram of extract (EQ µg/mg extract). The results 
are shown in table 1, showed that the extract (AcE) is the richest in 
polyphenols followed by ChE, whereas ChE is the richest in 
flavonoids followed by AcE. 
 
Table 1: Determination of total polyphenols and flavonoids in 
the extract of AA 
Extracts Polyphenols (a) Flavonoïds (b) 
CrE 9.94±0.008 1.88±0.43 
ChE 49.11±0.17 8.98±1.74 
AcE 60.31±0.70 3.78±0.78 
AqE 32.77±0.59 1.32±0.33 
(b) µg of Gallic acid equivalent per mg of extract 
(a) µg of quercetin equivalent per mg extract. 
Values represent the average of 3 measurements±SD. 
 
Effect of extracts on XO 
The inhibitory activity of the extracts on the XO was evaluated 
spectrophotometrically by following the decrease of the production 
of uric acid at 295 nm (XO activity). The results obtained showed 
that the inhibition is dose-dependent (Fig.1). To determine the 
relationship between the chemical structures of flavonoids and their 
inhibitory activity, we determined the type of inhibition for each 
extract. The results are shown in table 2. 
ChE and AcE inhibited XO noncompetitively, while the CrE and AqE 
are uncompetitive inhibitors. Inhibition of XO activity by the extracts 
resulted in the presence of one or more compounds acting 
independently or synergistically on the active sites of the enzyme. 
The position of the hydroxyl (-OH) is probably responsible for the 
type of inhibition. 
Several studies have evaluated the inhibitory effect of different 
plants on the XO and XOR activity [16-18, 7]. The inhibition of XO 
activity has been attributed to various compounds such as 
polyphenols and flavonoids [16, 19, 12, 20].  
There is a linear correlation between the content of polyphenols and 
XO Inhibition (R² = 0.9034), AcE extract is the richest in poly 
phenols, this extract exhibited the best inhibitory effect followed by 
ECh which is the richest in flavonoids. Based on the correlation 
between the concentration of polyphenols and flavonoids and XO 
inhibition by these extracts, our results are confirmed by those 
obtained by Boumerfeg et al., (2009) on the roots of Tamus 
communis [12], Wu et al., (2010) on Geranium sibiricum [19] and 
Baghiani et al., 2010 [21] on Carthamus caurulis, and Widyarini et al., 
(2015) on Cordifolia (ten) Steenis and Sonchus Arvensis L [22]. They 
found that the richest extracts phenolic compounds are the most 
active XO. Cos and his collaborators have shown in a study on a 
thirty flavonoids, inhibition of XO may be related not only on the 
content of polyphenols and flavonoids, but also the nature 
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(structure) of these compounds, glycoside extracts (AcE) and non 
glucoside (ChE) showed the highest inhibitory effect. CrE and AqE 
inhibited XO with a non-competitive manner, the same case of catechin, 
This is consistent [23]. Indicating that these extracts act differently on 
the enzyme, in this type of inhibition, the molecule reacts with the 
enzyme substrate after attaching, giving a non-functional complex.  
Berboucha and his collaborator [24] tested the XO inhibitory activity 
of a mixture of quercetin and catechin, in order to determine the 
effect of the simultaneous interaction of two potential inhibitors, the 
results showed a mixed type of inhibition. This means that the type 
of inhibition can be altered by the presence of other molecules 
present in the extract of plants by non-specific interactions. 
 
 
Fig. 1: Inhibition of XO by the extracts of Anchusa Azurea 
 
ChE and AcE have an inhibitory effect more or less significant (IC50= 
0.334±0.006 and 0.263±0.002 mg/ml, respectively). CrE and AqE 
weakly inhibit the XO activity, a concentration of 700 μg/ml and 800 
μg/ml reduced the activity of XO by 50%. XO inhibition by AcE and 
ChE was 134-times and 167-times, respectively, comparing to the 
IC50 of allopurinol (table. 2). 
 
Table 2: The determination of IC50 and the type of inhibition of extracts of Anchusa azurea 
Extracts IC50 (mg/ml) inhibition type 
CrE 0.828±0.108*** Uncompetitive 
ChE 0.334±0.006*** Noncompetitive 
AcE 0.263±0.002** Noncompetitive 
AqE 0.726±0.016*** Uncompetitive 
Allopurinol 0.002±0.00002 Competitive 
Quercetin Nd Competitive 
Catechin Nd  Uncompetitive 
Values are an average of 3 trials±SD. The comparison was realized against allopurinol.  
**: p ≤ 0.01, ***: p ≤ 0.001, and Nd: not deternined. 
 
Cos and his collaborator (1998) [16] measured the activity of a 
thirty flavonoids on the production of uric acid by XO. They have 
thus determined the relationship between the chemical structure of 
flavonoids and their inhibitory activity of this enzyme. The presence 
of the double bond between C2 and C3 carbons of the ring A flavonoid 
is very important for the inhibition. With a double bond between C2 
and C3, ring B will be coplanar with rings A and C due to the 
conjugation. Saturation of this double bond will destroy conjugation 
and coplanarity. This suggests that a planar flavonoid structure is 
important for inhibition of xanthine oxidase. 
In conclusion, to obtain an overall view of the inhibitory activity of 
XO extracts AA, an in vivo study is desirable on hyper urecemic 
models, based on the fact that a substance may be very active in vitro 
may lose this activity once penetrated into the body, and vice versa. 
Hypouricemic effects of extracts on potassium oxonate-induced 
hyperuricemia in mice  
Hyperuricemia is induced by intraperitoneally injection of 
potassium oxonate which is a competitive inhibitor of liver uricase, 
it partially blocks the conversion of uric acid to allantoin and 
therefore it increases the levels of uric acid in the mice serum giving 
an animal model hyper uremic [13, 15]. The uric acid, urea and 
creatinine were measured in serum and supernatant of the liver. 
We tried to verify the inhibitory effect of extracts of Anchusa 
azurea on the XO in vivo by measuring the uric acid level in serum 
and liver supernatant to confirm the in vitro inhibitory effect of the 
extracts and thus try to compare between the inhibitory effect in 
vitro and in vivo. 
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The value of uric acid in the control group: 1.48±0.07 mg/l, for the "OP" 
group, the uric acid level is significantly increased: 6.33±0.46 mg/l two 
hours after the intraperitoneal injection of potassium oxonate indicating 
that it has successfully induced hyperuricemia (table. 3). 
From the results obtained (fig. 2), it appears that treatment with all 
extracts decreased uric acid value compared to the control 
(1.48±0.07 mg/l). In the "PO" group, the uric acid levels increased 4 
times in the serum (6.33±1.22) and to almost two times for the liver 
supernatant (31.36±5.4 mg/l), the administration of 10 mg/kg of 
allopurinol decreased the rate of uric acid to the normal (1.89±0.32 
mg/l, 16.36±2.31 mg/l, respectively for serum and liver 
supernatant). 
AqE and CrE caused a decrease in serum uric acid (a decrease of 
66%) followed by ChE with a percentage of 29.22 %. The AcE keeps 
almost the same value of uric acid of "PO" group. For the 
supernatant, only CrE caused a significant decrease liver uric acid 
(18.5±4.8 mg/l). This decrease can be explained by the significant 
inhibition of the XO by inhibition of the synthesis pathways of uric 
acid [7]. The hypouricemic effect may be due to the inhibitory effect 
of these extracts on XO (IC50 (CrE) = 0.828±0.108 mg/ml, IC50 (AqE) 
= 0.726±0.016 mg/ml).  
These results are in contradiction with the results obtained in 
vitro, AcE and ChE present the best effect in vitro (IC50=0. 
263±0.002 mg/ml; IC50=0. 334±0.006 mg/ml), these extracts keep 
the same value of uric acid of PO group. However, CrE and AqE 
caused a similar decrease of uric acid (2.1±0.47 mg/l; 2.04±0.45 
mg/l) that allopurinol. This incoherence may be due to the 
difference in the bioavailability of flavonoids or polyphenols and 
metabolism in mice [15]. 
 
Table 3: Hypouricemic effects of extracts of Anchusa azurea 
 Serum uric acid (mg/l) Liver uric acid (mg/l) 
Control 1.48±0.07ns 17.9±1.591ns 
Allopurinol 1.89±0.1 16.36±1.033 
OP 6.33±0.46*** 30.18±2.141*** 
CrE 2.1±0.21ns 18.5±1.854ns 
ChE 4.48±0.33*** 21.45±1.854ns 
AcE 5.7±0.33*** 20.47±1.150ns 
AqE 2.04±0.20ns 20.08±1.028ns 
Comparison against the Allopurinol group, *** p ≤ 0.001, ns: not significant. 
 
Several researchers study on gout disease, they have shown that 
flavonoids can influence the activity of XO and thus can reverse the 
disease of gout by reducing both the concentrations of uric acid and 
inhibiting XO [25, 15]. Huang et his collaborators (2011) evaluated the 
effect of some flavonoid on the activity of XO in vitro and in vivo in 
serum and liver. They found that these flavonoids have not a 
significant effect in vitro. However, a slight decrease in serum uric acid 
levels between 8.6-16.5% was observed, they also found that there is 
no correlation between the activity of XO in vivo and in vitro [15].  
Renal function evaluation  
The objectives of this study is to evaluate the effect of the extracts on 
renal function. The rate of urea and creatinine levels can be 
indicators for the assessment of renal function. Kidney injury may be 
accompanied by an increase of creatinine and urea. 
In hyper uricemic mice, Allopurinol (10 mg/kg) increased the rate of 
creatinine and the urea level compared to normal control mice. All 
extracts of Anchusa azurea increased the urea but this increase is not 
significant, but they caused a very significant increase (P ≤0.001) of 
creatinine. The group "PO" have very significant increase (P ≤0.001) 
of creatinine and urea levels (p ≤0.01). Comparing the urea level of 
"OP" group (0.48 g/l), only extracts CrE-AA, AqE-AA (0.41g/l; 
0.39g/l) decreased the level of urea (P ≤0.05) by to the normal urea 
(0.34 g/l) (fig. 3). 
Alteration of the level of urea and creatinine can be caused by a 
number of factors other than renal disease, including the protein 
degradation, poor hydration, and liver failure. A decrease in the urea 
in the animals treated with the flavonoids may be inefficient due to 
the production of urea in the liver. The rate of formation of urea 
depends on the rate of protein catabolism, an increase of urea 
reflects an acceleration of the rate of protein catabolism and 
decrease the urinary excretion of urea [15].  
Therefore, we can conclude that the rate of urea and creatinine after 
treatment with plant extracts are normal and that the results of this 
study indicate the absence of renal damage in mice. 
 
 
Fig. 3: Renal function evaluation by the determination of urea and creatinine. The comparison against the control group, *** p ≤ 0.001, ns: 
not significant 
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CONCLUSION 
The medicinal plant Anchusa azurea is among the plants widely used 
today in traditional medicine in Algeria, In tests conducted in this 
study, a significant correlation between polyphenols content and 
inhibition activity of XO was observed. In our study, CrE and AqE 
extracts of Anchusa azurea did not show any significant effect on XO 
activity in vitro, but did have a significant effect on XO activities in 
vivo. Serum uric acid levels in mice treated with the flavonoids from 
CrE and AqE tested here were almost the same than those in normal 
control mice and those treated with allopurinol. Therefore, the 
extracts tested here can be a candidate for replacing allopurinol for 
the treatment of gout. 
These results remain preliminary, it would be interesting to test the 
activity of fractions and molecules that underlie the various 
activities detected in the different extracts. In addition, extensive 
further studies concerning the identification of phenolic compounds 
by more efficient methods are needed and a toxicological study is 
very requested.  
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